Market Overview:
The global dry eye disease market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of dry eye disease, rising awareness about the condition, and technological advancements in artificial tears and other treatment options. The global dry eye disease market is segmented by type into artificial tears, anti-inflammatory drugs, and other treatments. The artificial tears segment is expected to dominate the market during the forecast period owing to its high usage rates for treating symptoms of dry eye disease. The anti-inflammatory drugs segment is projected to grow at a higher CAGR than other segments during the forecast period due to its growing popularity as a treatment option for chronic cases of dry eye disease. The global dry eye disease market is also segmented by application into hospitals, drug stores, and online pharmacies. Hospitals are expected to account for the largest share of the market during the forecast period owing to their large patient base with chronic cases ofdry eyesight disorder .
Product Definition:
Dry Eye Disease is a condition that can affect anyone, but is most common in women. It occurs when the eyes do not produce enough tears or when the tears are not of the correct consistency. This can cause eye irritation, blurred vision, and other problems. Dry Eye Disease is important because it can lead to more serious conditions such as corneal ulcers if left untreated.
Artificial Tears:
Artificial tears are solutions that imitate the function of human tear fluid and help in lubricating eye surface. These products are available in different forms such as gels, liquids, and foam. Artificial tears can be used for treating dry eye disease or to prevent it from occurring in the first place.
Anti-inflammatory Drugs:
An anti-inflammatory drug is any medication that reduces inflammation. The most common types of drugs used for this purpose are nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and local anesthetics. Some examples of natural products in this category include turmeric/curcumin, resveratrol, and quercetin.
Application Insights:
Based on the application, the global dry eye disease market is segmented into hospital, drug stores and online pharmacies. Hospital was estimated as the largest revenue generating segment in 2017 due to increasing cases of ocular inflammation and pain. In addition, rising awareness about timely treatment is anticipated to boost industry growth over the forecast period.
The drug stores are expected to be fastest growing application segment owing to high availability of drugs in this store compared with others. Dry eye disease patients have a tendency of visiting different pharmacies for purchasing drugs since these shops sell affordable medicines along with quality products that help treat various diseases including dry eyes naturally without any side effects or complications associated with them (Artificial Tears). Thus, increasing demand from customers for purchasing artificial tears is expected drive industry growth over the forecast period.
Online pharmacy has been witnessing significant growth owing to easy accessibility.
Regional Analysis:
North America dominated the global dry eye disease market in 2017. The presence of a large patient pool and increased awareness levels coupled with the availability of advanced therapies are some factors attributing to its largest share. In addition, increasing R&D investments by major companies for developing novel therapeutics is expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to an increase in disposable income, high unmet clinical needs of patients along with rising awareness about Dry Eye Disease Treatment options & availability in emerging economies such as India and China.
The key players operating in this region are Bausch + Lomb (U.S.), Alcon (U.S.), Novartis AG (Switzerland), Pfizer Inc., Allergan Plc., and Merck & Co., Inc.
Growth Factors:
- Increasing prevalence of dry eye disease due to changing lifestyles and environmental factors.
- Growing awareness about the symptoms and treatment options for dry eye disease.
- Rising demand for ophthalmic devices and drugs for the treatment of dry eye disease.
- Technological advancements in ophthalmic devices that help in the diagnosis and treatment of dry eye disease.
- increasing number of mergers and acquisitions by key players in the market to expand their product portfolio
Scope Of The Report
Report Attributes
Report Details
Report Title
Dry Eye Disease Market Research Report
By Type
Artificial Tears, Anti-inflammatory Drugs, Other
By Application
Hospital, Drug Stores, Online Pharmacies
By Companies
Santen Pharma, Novartis, Llergan, Takeda, TRB Chemedica, Sun Pharmaceutical, Senju Pharmaceutical, Sentiss Pharma, Johnson & Johnson, Otsuka, Santen Pharma, FCI, Altacor, Valeant Pharmaceuticals, United Laboratories, Jianfeng Group, Eusan GMBH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Dry Eye Disease Market Report Segments:
The global Dry Eye Disease market is segmented on the basis of:
Types
Artificial Tears, Anti-inflammatory Drugs, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Stores, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Santen Pharma
- Novartis
- Llergan
- Takeda
- TRB Chemedica
- Sun Pharmaceutical
- Senju Pharmaceutical
- Sentiss Pharma
- Johnson & Johnson
- Otsuka
- Santen Pharma
- FCI
- Altacor
- Valeant Pharmaceuticals
- United Laboratories
- Jianfeng Group
- Eusan GMBH
Highlights of The Dry Eye Disease Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Artificial Tears
- Anti-inflammatory Drugs
- Other
- By Application:
- Hospital
- Drug Stores
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dry Eye Disease Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dry eye disease is a condition in which the eyes become dry and irritated. This can lead to vision problems, including blurred or reduced vision. Dry eye disease is most common in people over 50 years old, but it can occur at any age.
Some of the major companies in the dry eye disease market are Santen Pharma, Novartis, Llergan, Takeda, TRB Chemedica, Sun Pharmaceutical, Senju Pharmaceutical, Sentiss Pharma, Johnson & Johnson, Otsuka, Santen Pharma, FCI, Altacor, Valeant Pharmaceuticals, United Laboratories, Jianfeng Group, Eusan GMBH.
The dry eye disease market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dry Eye Disease Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dry Eye Disease Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dry Eye Disease Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dry Eye Disease Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dry Eye Disease Market Size & Forecast, 2020-2028
4.5.1 Dry Eye Disease Market Size and Y-o-Y Growth
4.5.2 Dry Eye Disease Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Artificial Tears
5.2.2 Anti-inflammatory Drugs
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Stores
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dry Eye Disease Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dry Eye Disease Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Artificial Tears
9.6.2 Anti-inflammatory Drugs
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Stores
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Artificial Tears
10.6.2 Anti-inflammatory Drugs
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Stores
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Artificial Tears
11.6.2 Anti-inflammatory Drugs
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Stores
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Artificial Tears
12.6.2 Anti-inflammatory Drugs
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Stores
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Artificial Tears
13.6.2 Anti-inflammatory Drugs
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Stores
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dry Eye Disease Market: Competitive Dashboard
14.2 Global Dry Eye Disease Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Santen Pharma
14.3.2 Novartis
14.3.3 Llergan
14.3.4 Takeda
14.3.5 TRB Chemedica
14.3.6 Sun Pharmaceutical
14.3.7 Senju Pharmaceutical
14.3.8 Sentiss Pharma
14.3.9 Johnson & Johnson
14.3.10 Otsuka
14.3.11 Santen Pharma
14.3.12 FCI
14.3.13 Altacor
14.3.14 Valeant Pharmaceuticals
14.3.15 United Laboratories
14.3.16 Jianfeng Group
14.3.17 Eusan GMBH
